IndraLab

Statements

signor
"Ruxolitinib is a selective inhibitor of Janus kinases (JAK) 1 and 2, which are involved in the signalling pathway of various cytokines and growth factors essential to haematopoiesis."
23061804
tas
No evidence text available
24417533
tas
No evidence text available
27137359
tas
No evidence text available
23061660
tas
No evidence text available
22591402
tas
No evidence text available
22037378
tas
No evidence text available
25369270
tas
No evidence text available
29298069
tas
No evidence text available
26927423
tas
No evidence text available
21106455
tas
No evidence text available
| DOI
tas
No evidence text available
23540648
tas
No evidence text available
22698084
tas
No evidence text available
24461299